Popular Stories

BIIB Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Can Nektar Therapeutics Bounce Back from its Massive Tumble?

Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its application for oxycodegol (formerly NKTR-181), as it received adverse advisory committee decision from both Anesthetic and Analgesic Drug Products Advisory Committee, and...

5 Promising Stocks In The Stroke Management Industry

An increase in the geriatric population, coupled with a rise in lifestyle diseases such as hypertension, diabetes and coronary cardiac diseases are driving the growth in the stroke diagnostics and therapeutics market not only in the US but in Europe and Asia as well. The market...

WordPress Video Lightbox Plugin